Portfolio Analysis Dashboard

📊 Investment Portfolio Dashboard

Connecting to APIs...

Healthcare Investment Research Report

Finding Your Next Position

Bottom Line: Boston Scientific offers the best risk-adjusted opportunity in healthcare right now - strong fundamentals, diversified revenue streams, limited regulatory exposure, and trading at reasonable valuations after sector-wide pullbacks.

Updated Portfolio Analysis & Strategy

October 13, 2025 • Post-Dip Positioning • Healthcare Additions Integrated

The AI Infrastructure Supercycle: Understanding Hyper Moore's Law

The most significant technological build-out since the internet is happening right now—and most investors are missing it.

📈 Live Market Data

Real-time prices powered by Finnhub API • News from NewsAPI

Loading... Connecting to live data sources...

Your Portfolio - Live Prices

Ticker Live Price Change Change % Volume
BSX Loading... -- -- --
UNH Loading... -- -- --
MDT Loading... -- -- --
HIMS Loading... -- -- --
NBIS Loading... -- -- --

📰 Latest Financial News

Loading latest market news...

Investment Portfolio Report

Public Edition — October 2025 • Shareable Version (No Monetary Amounts) • Base Currency: GBP

Executive Summary

Positioning
Growth-tilted with concentrated exposure to AI/Semiconductors and Cloud; sizeable cash reserve for staged redeployment
Key Opportunities
Portfolio has strong exposure to AI infrastructure and quality tech names, with meaningful cash buffer providing flexibility
Key Risks
~50% concentration in AI-adjacent sectors creates single-narrative risk; several positions have run significantly and may face momentum reversal. Valuations and momentum suggest tactical rebalancing is prudent.
Strategic Focus
Reduce AI exposure from 50% to 35-40% through systematic profit-taking; add defensive diversification while maintaining core quality positions

Portfolio Allocation & Holdings

Cash Reserve Semiconductors & Hardware Fintech & Payments Cloud / Data / Cyber Consumer Platforms Healthcare & Bio ETFs & Funds Energy / Industrial Quantum & Frontier Consumer/Materials

Cash Reserve — ~30%

Dry powder for opportunities and staged redeployment

Semiconductors & Hardware — 16%

  • ASML
    EUV/DUV lithography machines used to manufacture the smallest chips
  • AVGO
    Broadcom — Networking/RF/custom accelerators + infrastructure software (VMware)
  • TSM
    Leading advanced-node foundry for Apple/Nvidia/AMD, etc.
  • AMD
    CPUs/GPUs; fast-growing in data-center AI accelerators (MI series)
  • INTC
    CPU leader in turnaround; building foundry business (Intel Foundry Services)
  • NVTS
    Navitas — GaN/SiC power semis for fast chargers, EVs, data centers

Cloud / Data / Cyber (10%)

  • SNOW
    Data cloud: storage + compute + apps ecosystem
  • MDB
    MongoDB database platform; Atlas is the cloud DBaaS
  • PLTR
    Gov/enterprise data platforms (Gotham/Foundry/AIP)
  • CRWD
    Cloud-native endpoint/identity/data security (Falcon)
  • PEGA
    Low-code workflow/decisioning & CRM
  • NBIS
    Nebius Group — Cloud/AI infrastructure provider

Fintech & Payments (11%)

  • WISE
    Low-cost cross-border payments, multi-currency accounts/cards
  • NU
    High-growth LatAm digital bank (deposits/credit)
  • FOUR
    Shift4 — Merchant acquiring + integrated payments
  • LMND
    AI-driven digital insurer
  • MARA
    Bitcoin miner (very high beta to BTC)
  • DLO
    Cross-border payments for global merchants

Consumer Platforms (9%)

  • META
    Facebook/Instagram/WhatsApp + VR/AR (Reality Labs)
  • NFLX
    Streaming entertainment leader
  • GOOGL
    Search/YouTube/Cloud/AI
  • RBLX
    User-generated gaming platform
  • DUOL
    Language learning app
  • TTD
    The Trade Desk — Programmatic ad buying platform
  • CPNG
    Coupang — Korean e-commerce
  • JMIA
    Jumia — African e-commerce
  • DKNG
    DraftKings — Online sports betting

Healthcare & Biotech (7%)

  • HIMS
    Hims & Hers — Telehealth & direct-to-consumer prescriptions
  • CLPT
    ClearPoint Neuro — Surgical navigation for brain procedures
  • HROW
    Harrow — Ophthalmology pharmaceuticals
  • ASPN
    Aspen Aerogels — Aerogel insulation materials
  • TEM
    Tempus AI — Precision medicine & genomic data

ETFs & Index Funds (6%)

  • VWRL
    Vanguard FTSE All-World UCITS ETF
  • VUSA
    Vanguard S&P 500 UCITS ETF
  • VUKG
    Vanguard FTSE UK All Share UCITS ETF
  • VERG
    Vanguard FTSE Emerging Markets UCITS ETF
  • LS100
    Vanguard LifeStrategy 100% Equity
  • LS20
    Vanguard LifeStrategy 20% Equity
  • VPACXJ
    Vanguard Pacific ex-Japan UCITS ETF
  • IWRD
    iShares MSCI World UCITS ETF

Energy & Industrial (5%)

  • GEV
    GE Vernova — Energy equipment spin-off from GE
  • PNG
    Cadence Design Systems — Electronic design automation
  • IRE
    International Renewable Energy — Clean energy
  • ASTS
    AST SpaceMobile — Space-based cellular broadband
  • INVX
    Innovex — Oil & gas equipment
  • JOBY
    Joby Aviation — Electric air taxis (eVTOL)

Quantum & Frontier Tech (4%)

  • IONQ
    IonQ — Trapped-ion quantum computing
  • RGTI
    Rigetti Computing — Superconducting quantum processors
  • QBTS
    D-Wave Quantum — Quantum annealing systems
  • INOD
    Innodata — AI data services & annotation
  • OKLO
    Oklo — Advanced nuclear fission (microreactors)

Consumer & Materials (2%)

  • HFG
    Hilton Food Group — Food packaging & processing
  • CRML
    Critical Metals — Rare earth minerals

Performance & Recommendations

Top Performers Requiring Action

Ticker Performance Action Rationale
INOD +129% Trim 30-40% Massive momentum run; frontier tech carries high reversal risk
NBIS +116% Trim 20-30% Strong cloud play but extended valuation warrants de-risking
OKLO +69% Trim 25-35% Nuclear/energy momentum trade; lock gains ahead of potential volatility
INTC +43% Trim 30-50% Turnaround thesis intact but execution risk remains high
HIMS +31% Hold Healthcare diversification play with solid fundamentals
WISE +15% Hold/Add Core fintech position; reasonable valuation with growth runway
META -2% Hold/Add dips Quality megacap with AI optionality; dips are buying opportunities

Tactical Rebalancing Strategy

1-Month Horizon: Systematic Profit-Taking

  • Trim positions up 50%+ to lock in momentum gains
  • Priority sequence: INOD → NBIS → OKLO → INTC
  • Target: Raise cash buffer from 30% to 35%

3-6 Month Horizon: Strategic Diversification

  • Reduce AI exposure from 50% to 35-40%
  • Add 8-10% healthcare ETF allocation (WHEA/IUHC)
  • Build 3-5% gold hedge (SGLN/PHGP)
  • Maintain core quality positions (META, WISE, AVGO)

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups

Please allow a few minutes for this process to complete.

Report

You have already reported this .
Scroll to Top